Barclays’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.48M | Sell |
59,405
-15,475
| -21% | -$1.43M | ﹤0.01% | 1551 |
|
2025
Q1 | $6.63M | Sell |
74,880
-5,527
| -7% | -$489K | ﹤0.01% | 1260 |
|
2024
Q4 | $6.18M | Buy |
80,407
+61,486
| +325% | +$4.73M | ﹤0.01% | 1429 |
|
2024
Q3 | $803K | Buy |
18,921
+14,681
| +346% | +$623K | ﹤0.01% | 2749 |
|
2024
Q2 | $111K | Buy |
+4,240
| New | +$111K | ﹤0.01% | 3326 |
|
2023
Q2 | – | Sell |
-5,318
| Closed | -$64K | – | 4428 |
|
2023
Q1 | $64K | Buy |
5,318
+4,032
| +314% | +$48.5K | ﹤0.01% | 3711 |
|
2022
Q4 | $12K | Buy |
1,286
+1,083
| +533% | +$10.1K | ﹤0.01% | 4113 |
|
2022
Q3 | $6K | Sell |
203
-333
| -62% | -$9.84K | ﹤0.01% | 4348 |
|
2022
Q2 | $22K | Buy |
536
+212
| +65% | +$8.7K | ﹤0.01% | 4055 |
|
2022
Q1 | $33K | Buy |
+324
| New | +$33K | ﹤0.01% | 4164 |
|